Posters

iStent implants in a procedure combined with cataract phacoemulsification: own observation

Poster Details

First Author: E.Mrukwa-Kominek POLAND

Co Author(s): L. Drzyzga   W. Lubon   M. Swoboda   M. Hajduga           

Abstract Details

Purpose:

Nowadays, there is an increased interest in microinvasive glaucoma surgery (MIGS) which have become widely available for the patients with glaucoma disease. The study presents data on efficacy, tolerance and impact on lowering intraocular pressure (IOP) of surgical technique of implanting iStent medical implants in a procedure combined in the same time with cataract phacoemulsification

Setting:

1 Department of Ophthalmology, Katowice Division, Medical University of Silesia, Poland 2 Department of Ophthalmology, Professor K. Gibinski University Clinical Center of the Medical University of Silesia, Katowice, Poland

Methods:

Fifteen patients diagnosed with primary open angle glaucoma and associated cataracts were qualified for simultaneous cataract phacoemulsification and implantation of the iStent device. Intraocular pressure was measured immediately before the procedure using applanation tonometry, followed by the control schedule 1 day- 1 week- 2 weeks after surgery. During the postoperative controls, the local condition of the ocular surface and the location of the iStent implants using the gonioscopy were also checked

Results:

Already on the first day after the surgery, there was a significant decrease in intraocular pressure of 8.1 mmHg. After 1 week, IOP was lowered by 9.9 mmHg, second week by 9.4 mmHg, as compared to the value before surgery. There were no adverse events during the surgery. 3 patients had a trace of blood in the anterior chamber on the first day. Treatment resulted in a marked decrease in IOP, which resulted in discontinuing of treatment used so far in 11 patients and a significant reduction in the anti-glaucoma treatment in 7 patients. UCVA/BCVA improved significantly (p<0.05)

Conclusions:

Micro-invasive glaucoma surgery with iStent implantation combined with cataract phacoemulsification seems to be an effective solution in the treatment of primary open angle glaucoma. They enable significant reduction of intraocular pressure, allow some patients to stop pharmacological intraocular pressure lowering treatment or reducing the amount of anti-glaucoma drops. In addition, these operations show an excellent safety profile.

Financial Disclosure:

None